A. Tourna

Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma

Y. Zen, T. Itoh, N. Youngson, 2021, Virchows Archiv.

Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death

N. Youngson, F. Peyvandi, S. Chokshi, 2022, Scientific Reports.

GENETICS AND EPIGENETICS IN THE CLINIC: PRECISION MEDICINE IN THE MANAGEMENT OF FATTY LIVER DISEASE.

N. Youngson, Luca Valenti, A. Cespiati, 2020, Current pharmaceutical design.

Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease

N. Turner, S. Rozen, P. Campbell, 2021, Genome Medicine.

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

E. Bugianesi, S. Chokshi, G. Baselli, 2023, Nature Medicine.